Amgen Inc (BSP:AMGN34)
R$ 58.14 0 (0%) Market Cap: 881.03 Bil Enterprise Value: 1.20 Til PE Ratio: 34.15 PB Ratio: 19.04 GF Score: 86/100

Amgen Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2020 / 09:15PM GMT
Release Date Price: R$45.95 (+2.18%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

And there we are. We're live, unceremoniously like that. Well, my name is Evan Seigerman. I'm the senior large-cap biopharma analyst here at Crédit Suisse. And it's my pleasure to introduce Amgen on the first day of our Virtual Healthcare Conference. I'm looking forward to next year when we can all be in person. We were reminiscing about how nice that was. But from Amgen, we have Peter Griffith, CFO; Murdo Gordon, Global Commercial Operations; and of course, Arvind Sood, VP of IR.

I was told very specifically to give it to Arvind after the introduction. So Arvind, take it away.

Arvind Sood
Amgen Inc. - VP of IR

Evan, thank you very much. Good afternoon, everybody. I really appreciate this opportunity. As you mentioned, Evan, we would much rather be at The Phoenician in Scottsdale, but that's kind of the way it is right now.

So Evan, let me just tee up some key topics, and then we can move on to your questions. Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot